X-Chem forges an­oth­er dis­cov­ery deal, this time with Ver­tex

The cys­tic fi­bro­sis spe­cial­ist Ver­tex signed a drug dis­cov­ery pact with Waltham, MA-based X-Chem.

In the deal, which comes with an un­spec­i­fied set mile­stones and an up­front, X-Chem will put its li­brary of “120 bil­lion small mol­e­cules” to work in search of rare ge­net­ic dis­ease drugs for Ver­tex, which is look­ing down the line to grow­ing its pipeline be­yond cys­tic fi­bro­sis.

There’s an op­tion to ex­pand the pact at a lat­er point. And gaz­ing well in­to the fu­ture, X-Chem al­so has a shot at roy­al­ties on any ap­proved prod­ucts that come out of the pact.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.